Are There Alternative Approaches to Reduce Rejection?
Researchers are exploring alternatives to traditional immunosuppression to reduce toxicological risks. One promising approach is T-regulatory cell therapy, which aims to modulate the immune response naturally. Another area of research focuses on enhancing the compatibility of donor organs through genetic engineering, potentially reducing the need for lifelong immunosuppression.
